GenEra Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 12
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

GenEra General Information

Description

Operator of a biotechnology company specializing in the fields of gene transfer and gene therapy. The company develops a variety of genetically modified tissues as a means of treating a range of diseases that are caused by defects in circulating proteins and other molecules, such as high cholesterol levels.

Contact Information

Website
generaspa.it
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
MolMed
Primary Office
  • Istituto Scientifico H. San Raffaele
  • Via Olgettina, 58
  • 20132 Milan
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GenEra Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenEra‘s full profile, request access.

Request a free trial

GenEra Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GenEra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2415999-A A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes Abandoned 23-Dec-1997 000000000
EP-1030908-A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy Withdrawn 14-Nov-1997 0000000000
CA-2310016-A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy Abandoned 14-Nov-1997 0000000000
AU-1872599-A Genetically-modified myogenic progenitors and their use in cell and gene therapy Abandoned 14-Nov-1997 0000000000
JP-2001523448-A Genetically modified myogenic precursors and their use in cells and gene therapy Pending 14-Nov-1997 C12N5/0663
To view GenEra’s complete patent history, request access »

GenEra Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial